Received Feb 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946912 | IM / RA |
Pt reported very itchy diffuse rash/hives to body 4 days following injection. Pt reports today 2/10/26 that she is still experiencing a rash even following treatment with oral and topical steroids.